MRD / Regn No. : SG001628 Date : 16/07/2026
Patient Name : Mominul Islam Monna Age & Gender : 25 Yrs. / Male
Contact No. : 1790969483 UHID :
Ht / Wt / BMI : 163 / 70 / 26.35 BP S / BP D : 120 / 76
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (25/Aug/2021) | NAFLD (25/Aug/2023) |
Salient Investigations : ALT ALANINE AMINOTRANSFERASE: 59 IU/L | CREATININE: 0.8 | EGFR EGLOMERULAR FILTRATION RATE: 125.36 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 339 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 14.2 % | LDL LOW DENSITY LIPOPROTEIN: 225 mg/dL | MICROALBUMIN CREATININE RATIO: 91 mcg/mg | TGL TRIGLYCERIDE: 449 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + LINAGLIPTIN 5 MG
ZEXRIDA L
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
2 GLIMEPIRIDE 4 MG + METFORMIN 1000 MG
GLYCOMET GP 4 FORTE
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
3 INJECTION DEGLUDEC (INJ U100)
TRESIBA
Medicine For DIABETES
SQ 0-0-20 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
4 TABLET ROSUVASTATIN 20 MG
STATEZE R 20
PO 0-0-1 BEFORE DINNER
TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 16/Jan/2027
Tests Suggested For Next Visit : SMBG,HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: